Entellus Medical (ENTL)Posts Q3 Loss of 32c/Share; Updates FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts ENTL Hot Sheet
Join SI Premium – FREE
Entellus Medical (NASDAQ: ENTL) reported Q3 EPS of $0.32, versus the analyst estimate of ($0.25). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.19 million.
Entellus Medical sees FY2015 EPS of ($1.12)-($0.99), versus the consensus of ($0.92). Entellus Medical sees FY2015 revenue of $605-61.5 million, versus the consensus of $60.4 million.
For earnings history and earnings-related data on Entellus Medical (ENTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue Airways (JBLU) Misses Q3 EPS by 6c, Misses on Revenue
- Agilysys, Inc. (AGYS) Tops Q2 EPS by 12c, Beats on Revenue; Offers FY27 Revenue Guidance
- Dorman Products (DORM) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
